NCT02259764View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

KUC 7483 CL - single rising dose

DRUG

Placebo

OTHER

standardized high fat meal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02259764 - Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter